The purpose of this paper was to investigate the aggregation of amphotericin B (AMB) and AMB-arabinogalactan conjugate (AMB-AGC), and the interactions of these drugs with free and membrane-embedded sterols. Aggregation of AMB and AMB-AGC was studied by circular dichroic (CD) and UV absorbance spectroscopic techniques. The effect of liposomes on the spectra was utilized to investigate the interactions of aggregates with membrane-embedded sterols. Interaction with free sterols was studied by measuring sterols' effect on AMB/AMB-AGC susceptibility test. The results demonstrated that AMB-AGC forms unique aggregates in aqueous solution which differ from those formed by free AMB. Ergosterol and cholesterol embedded in liposomes, affected the CD spectra obtained for both AMB and AMB-AGC, indicating interactions of these sterols with both drugs. Interaction with both cholesterol and ergosterol resulted in an increase of AMB-AGC's minimal inhibitory concentration (MIC) in Candida albicans. In conclusion, AMB-AGC forms unique aggregates in aqueous solution; these aggregates interact with membrane-embedded cholesterol and ergosterol and with free sterols. These results indicate that the selectivity of AMB-AGC to fungal cells may not occur due to inability to bind cholesterol but probably as a result of this unique aggregation. Understanding this mechanism may help to develop a safer AMB formulation for therapy.
Introduction
Amphotericin B (AMB) is one of the most effective antifungal agent. [1] [2] [3] [4] However, dose-related toxicity limits the use of Fungizone TM , the most common deoxycholate micellar AMB formulation. [5] [6] [7] [8] AMB liposomal formulations such as AmBisome TM are significantly less toxic, [8] [9] [10] but their broad use is limited by their high cost per treatment. We previously reported on the development of a water-soluble, low-cost, and less toxic formulation of AMB by conjugation to the polysaccharide arabinogalactan (AG). In vitro and in vivo experiments demonstrated that the AMB-AG conjugate (AMB-AGC) is highly effective against fungal cells, similar to the clinically used Fungizone and AmBisome. [11] [12] [13] Conjugation prevented all known toxic effects of AMB in mammalian cells, including disruptive changes and apoptosis in renal tubular cells, plasma membrane perforation and modulation of intracellular trafficking and endosomal alkalization, 14, 15 , while keeping the antifungal activity as was demonstrated by low MIC values (0.12-0.50 mg/l) in various fungal species and strains including Candida albicans ATCC 90028 (this study), Candida albicans CBS 562, 11 Cryptococcus neoformans B-3501, 11 Saccharomyces cerevisiae CRY1 15 and Aspergillus fumigatus ATCC 64026. 16 Pre-aggregation of AMB molecules in the surrounding aqueous solution is a prerequisite for polar-channel formation in cholesterol-containing membranes (mammalian). In ergosterol-containing membranes (fungi) on the other hand, monomeric AMB molecules are sufficient to form polar channels. [17] [18] [19] [20] [21] [22] [23] In addition, it has been recently suggested that AMB binding to ergosterol also contributes to its fungicidal effect, even in the absence of channel formation, 24 and that an AMB derivative was exclusively active against fungi due to its ability to bind ergosterol but not cholesterol. 25 Consequently, in order to understand the mechanism underlining AMB-AGC selective activity against ergosterol-containing fungal cells, we studied the effect of AMB conjugation to AG on the aggregation of AMB residues. Using circular dichroism (CD) spectroscopy and UV absorbance spectra, we investigated whether this aggregation is modified or prevented by the conjugation and studied the interaction of AMB and AMB-AGC with free sterols and with membranes containing different sterols. Polymer synthesis AMB-AGC was synthesized by conjugation of AMB to oxidized AG by reductive amination, as previously described. 11, 12 In brief, AG was dissolved in DDW (0.1 g/ml, 0.625 mmol/ml). To the clear solution potassium periodate was gradually added at a 1:1 mole ratio (IO 4 − /AG units).
Materials and methods

Materials
The reaction continued in the dark at 25 ± 2 • C for 2 h. The polyaldehyde was purified by anion exchange chromatography (Dowex-1 in acetate form), followed by dialysis against DDW (5 L × 4) (12,000 cutoff cellulose tubing) at 4 • C for 3 days. The purified polyaldehyde was freeze-dried. Yield, 75% ± 5% (w/w), MW 11 KDa. FT-IR (KBr); 1724 per cm (C=O). Oxidized AG (10 mg/ml, 3.87 mmol/g aldehyde groups) was dissolved in 0.1 M borate buffer (pH 11 ± 0.1) at room temperature followed by addition of AMB (2.5 mg/ml; 950 U/mg) to the solution. The mixture was gently stirred in a light-protected container at room temperature for 48 h (the pH of the mixture kept at 11 ± 0.1) and dialyzed against DDW (4 × 5 l) at 4
• C, (12,000 cutoff cellulose tubing), followed by lyophilization obtaining the yellow-orange imine-based conjugate. The iminebased conjugate was reduced with an excess of sodium borohydride, 1:2 mole ratio (AG units/NaBH 4 ) at 25
• C for 24 h to obtain the amine-based conjugate. The solution was dialyzed as described above followed by freeze-drying. The dry yellow powder was kept at 4
• C. Yield 80% (w/w).
The AMB content in the AMB-AGC was 20 ± 2% (w/w) as determined by spectrophotometric measurement of AMB (UV, λ = 390 nm). 
Antifungal susceptibility testing
Minimal inhibitory concentrations (MICs) of AMB and AMB-AGC were determined according to CLSI recommendations 26 for microbroth dilution medium with Candida albicans ATCC 90028 (American Type Culture Collection, Manassas, VA). Ergosterol at a final concentration of 20 mg/l or cholesterol at 20 and 50 mg/l were added to the RPMI broth medium (Sigma). RPMI broth medium lacking sterols was used as a control. A representative result of one out of four different experiments with similar results (performed in duplicates).
Liposome preparation
A solution of 2.5 mg/ml EPCS in DCM was prepared and used for the preparation of all three kinds of liposomes:
(A) cholesterol-embedded liposomes −1.40 mg cholesterol dissolved in DCM was added to the EPCS solution; (B) ergosterol-embedded liposomes-1.44 mg ergosterol dissolved in DCM:methanol 2:1 (v/v) was added to the EPCS solution; (C) EPCS (plain) liposomes-EPCS in DCM solution was used. All samples were dried by evaporation followed by freeze-drying. Liposomes with mean diameters of around 120 nm were prepared by rehydration for 2 h in PBS and extrusion homogenization with extruder device (Northern lipids, Vancouver, BC, Canada) using polycarbonate filters (three times with a 400-nm pore-size filter and then three times with an 80-nm filter).
Results
AMB-AGC synthesis
AMB-AGC was synthesized by Schiff base reaction of the AMB with oxidized AG. The imine conjugate based formed was reduced with an excess of NaBH 4 to produce the aminebased water soluble conjugate, containing 20% of AMB as determined by UV spectrophotometry. Molecular weight of the conjugate was ∼ 20 KDa. The general structure of the conjugate is depicted in Figure 1 .
AMB and AMB-AG aggregation
AMB and AMB-AGC monomers' spectra were determined in DMSO (10 −4 M AMB equivalent). The UV absorbance spectrum of AMB-AGC in DMSO was similar to that of AMB (peaks at 374, 394, and 420 nm; Fig. 2a ).
The CD spectrum of AMB in DMSO (Fig. 2b ) revealed AMB monomers with peaks at 372, 394, 418 nm, as expected. 27, 28 The CD spectrum for AMB-AGC was very similar to that of AMB, with a slight shift of the strong bands to red (peaks at 374, 398, 422 nm), and a decrease in peak intensity, especially of the peak at 374 nm. AMB is known to produce aggregates at high concentrations in aqueous solutions. 27 ,29 Therefore, we examined the behavior of 10 −4 M AMB and AMB-AGC in PBS. Diluting the stock solution of AMB-DMSO in PBS resulted in disappearance of the monomer absorption peaks and appearance of a new peak at 340-345 nm (Fig. 2c) , as reported for AMB aggregates. 21, 28, 29 The CD spectrum included a dichroic doublet centered around 344 nm, a positive sign for the lower wavelength (325 nm), a negative peak at 371 nm, and two shoulders at 388 and 417 nm (Fig. 2d) , resembling a typical AMB aggregate spectrum. 21 ,28,29 AMB-AGC diluted in PBS exhibited spectral behavior that was completely different from that of free AMB. The UV spectrum exhibited an intense peak at 353 nm, with a shoulder at 368 nm, and two additional peaks at 393 and 413 nm (Fig. 2c) . The CD spectrum showed a dichroic doublet centered around 359 nm, with a positive sign for higher wavelengths (375, 396, and 427 nm), and a negative peak at 345 nm (Fig. 2d) , which was almost the mirror image of the AMB spectrum with a slight shift to higher wavelength. When AMB and AMB-AGC were diluted in PBS to 10 −6 M (AMB equivalent), the CD profiles were similar to those observed at a concentration of 10 −4 M in PBS, and the UV absorbance spectra were similar to those of the monomeric forms (data not shown). These results suggest the coexistence of monomeric and aggregated forms. 29 To rule out the possibility that the different aggregation is simply due to the presence of AG in the solution, we examined the spectra of a mixture of free AMB (10 −4 M) and AG (0.37 g/l) in PBS (similar to the ratio of AMB to AG in the conjugate). The observed UV absorbance and CD spectra were very similar to that of free AMB (Figs. 3a and 3b) , indicating that the unique aggregation is not a consequence of the presence of AG adjacent to the AMB molecules.
AMB and AMB-AGC interaction with ergosterol and cholesterol
Binding of AMB to ergosterol has been recently shown to contribute to its antifungal activity, even in the absence of polar-channel formation. 24 We investigated the interactions of AMB-AGC with free and membrane-embedded cholesterol and ergosterol. Ergosterol or cholesterol are known to bind AMB and inhibit its antifungal activity with higher inhibition seen with ergosterol when using susceptibility test. 30 In the present study, addition of both sterols to the RPMI medium of the susceptibility test decreased the antifungal activity of AMB-AGC, as indicated by the higher MIC values of AMB-AGC compared to control lacking sterols (Table 1 , similar data were obtained with eight clinical isolates of Candida albicans). This inhibitory effect of both sterols was stronger than the effect on free AMB (Table 1) , thus indicating stronger avidity of both sterols to AMB-AGC rather than to free AMB and ruled out inability of AMB-AGC to bind cholesterol. Additionally, in order to investigate the interactions of AMB and AMB-AGC with membraneembedded sterols, we examined the effect of liposomes containing ergosterol and cholesterol on the CD profile of free AMB and AMB-AGC. When ergosterol and cholesterol were embedded in liposomal membranes (Fig. 4) , they significantly reduced the amplitude of the dichroic dou- blet peaks of AMB-AGC, compared to liposomes lacking sterols. This phenomenon indicates that AMB-AGC interacts with membrane-embedded sterols. Interestingly, no significant difference between the ability of AMB-AGC to interact with ergosterol/cholesterol-embedded membranes was observed (Fig. 4) . Cholesterol and ergosterol containing liposomes also changed the CD profile of free AMB. However, the new CD profiles were not just a reduction of the original profiles but also included two new peaks instead of the single peak at 325 nm (Fig. 4) .
Discussion
The predominance of the monomeric form of AMB in DMSO is well documented in the literature. 27, 31, 32 The UV absorbance spectrum of AMB-AGC in DMSO was similar to that of AMB (peaks at 374, 394, and 420 nm; Fig. 2a ) and resembled that reported for AMB monomers. 27, 28 AMB is known to produce aggregates at high concentrations in aqueous solutions; 27,29 therefore, we examined AMB and AMB-AGCs spectra in PBS. The UV and CD spectra of AMB and AMB-AGC (10 −4 M in PBS) differed from each other. Jameson and Dzyuba reported the manifestation of unique aggregates of AMB in ionic liquid solutions when analyzed by CD. 33 The CD spectrum of AMB in aqueous solution is similar to that of natural conjugated polyenes such as carotenoids. 34 We compared the CD spectra of AMB and AMB-AGC in PBS to those of various carotenoids; the AMB spectrum resembled that of the aggregated carotenoid 3 S, 6 R-capsanthol, while the spectrum of AMB-AGC resembled that of 3 R, 6 R-capsanthol which forms different aggregates. 35, 36 These results indicated the formation of unique aggregates by AMB-AGC, which differ from those formed by free AMB. The fact that the spectra of mixture of free AMB with AG were nearly identical to that of free AMB alone, ruled out the possibility that the unique aggregation is a consequence of the presence of AG adjacent to the AMB molecules. It has been reported recently that AMB binding to ergosterol plays a critical role on AMB's activity, allowing antifungal activity even in the absence of polar-channel formation, 24 and that an AMB derivative was exclusively active against fungi due to its ability to bind ergosterol but not cholesterol. 25 Therefore, we investigated whether AMB-AGCs' selectivity to fungal cells is a consequence of inability to bind cholesterol, while conserving ergosterol's binding ability. We show that both ergosterol and cholesterol increased MIC values of AMB-AGC compared to control lacking sterols, and the effect was stronger than that of free AMB, indicating stronger avidity of both sterols to AMB-AGC rather than to free AMB. The use of liposomes to understand interactions with membranes, indicated that AMB-AGC interact with membrane-embedded sterols without a significant difference between ergosterol and cholesterol. These results ruled out inability of AMB-AGC to bind cholesterol. We previously reported on clear differences in the ability of AMB-AGC to perforate ergosterol membranes compared to its inability to perforate cholesterol membranes. 15 Our results suggest that channel formation, and not simply sterols' binding, is responsible for the high selective activity of AMB-AGC against fungal compared to mammalian cells. Thus, AMB binding to ergosterol is sufficient for its antifungal activity 24 (with additional contribution of channel formation), while channel formation is probably needed for the cytocidal activity in mammalian cells. Cholesterol and ergosterol containing liposomes changed the CD profile of free AMB and AMB-AGC. However, while both types of liposomes reduced the amplitudes in AMB-AGC CD profile, the new CD profiles of free AMB were not just a reduction of the original profiles but also included two new peaks instead of the single peak at 325 nm. This may indicate differences between AMB and AMB-AGC interaction with sterols. Furthermore, the interactions of AMB-AGC with ergosterol-embedded liposomes suggest that the interaction between AMB-AGC and membrane containing ergosterol is universal and not unique to a particular fungal strain or species. In summary, AMB-AGC forms unique aggregates in aqueous solution, which differ from AMB aggregates and do not perforate cholesterol-containing membranes (mammalian membranes). Additionally, AMB-AGC interacts with both ergosterol and cholesterol, but its interactions are somewhat different from free AMB interaction. The finding that AMB-AGC interacts in a similar way with cholesterol and ergosterol, rules out the possibility that the selective activity of the drug is due to its inability to bind cholesterol. Wasko et al. 37 reported that membrane perforation by AMB's aggregates is responsible for AMB's adverse effects. Our results indicate that the selectivity of AMB-AGC, as well as the neutralization of the adverse effects of the free AMB are a consequence of the inability of the conjugate to perforate mammalian membranes. The inability to perforate mammalian membranes is probably a result of the different type of aggregates and the ways they interact with sterols. The AMB-AGC retains its antifungal activity, probably due the fact that some AMB residues in the polymeric conjugate preserve their monomeric structure (as shown at 10 −6 M concentration), thus enabling perforation of ergosterol-containing membranes (fungi). Our results are in agreement with additional studies, showing different therapeutic index to different types of AMB aggregates. 38, 39 Understanding the mechanism of reduced AMB cytocidal activity may help to develop a safer AMB formulation for therapy.
